SOLICITATION NOTICE
66 -- Reoptimization of Cbot Type A Strains
- Notice Date
- 5/31/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, Center for Disease Control and Prevention, Spokane Research Laboratory, 315 East Montgomery Avenenue, Spokane, WA, 99207, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- 000HCVHE-2007-43002
- Response Due
- 6/15/2007
- Archive Date
- 6/30/2007
- Small Business Set-Aside
- Total Small Business
- Description
- The Centers for Disease Control (CDC), National Center for Infectious Diseases (NCID)in Atlanta, GA intends to negotiate with Fluoresentric, Inc. in Park City, UT. NCID is validating a proprietary real-time PCR assay which was developed by Fluoresentric (Park City, UT) that is capable of detecting the genes for botulinum toxin types A through G using the Lightcycler platform with Taqman chemistry. These assays will be utilized by laboratories responding to intentional or unintentional outbreaks of botulism. Single target assays (singleplex) will be available for each of the seven toxin types A through G. We require that type A, B, E, and F assays will be provided as follows: i) 7000 reactions of each type be provided as 200 lyophilized reactions per tube and ii) 3000 reactions of each type be provided as 100 lyophilized reactions per tube. For types C, D, and G assays we require that all 1000 reactions be provided as 100 lyophilized reactions per tube. Assays will be required to have a sensitivity of less than or equal to 10 copies. Assay sensitivity will be determined using dilutions of a known quantity of a synthetic template whose sequence is identical to that of the amplicon. Assays will be required to have no cross-reactivity to other Clostridia spp., between botulinum toxin types, or among enteric bacterial pathogens. Finally, the lyophilized product must have a shelf life equal to or greater than 6 months when stored at 4oC. Fluoresentric will provide technical support by telephone and/or internet. In addition, Fluoresentric will provide the oligonucleotide sequence information in order to permit CDC to reconstitute the assay, if necessary. The vendor will provide quality control results to CDC for each lot of assays delivered to confirm that the reactions perform as stated above. CDC will test each lot of the finished goods to confirm that the assays conform to the specifications described above. In order to ensure that the assays specifications are met, it is critical that the assay design be identical among lots. Therefore, the assay must contain the identical oligonucleotide sequences, PCR conditions, specificity, and sensitivity as that developed by Fluoresentric. Firms that believe they can provide the required services are encouraged to identify themselves and give a written capabilities statement to the Contracting Officer within 15 days from the date of this presolicitation notice. A determination not to compete thisproposed action based on responses to this notice is solely within the discretion of the Government. All vendors must be registered in the Central Contractor Registry (CCR) prior to award of a Federal contract. Vendors may register at www.ccr.gov. Please address all inquiries to Denise Rains (509)354-8111, (509)354-8099 fax or email DGR8@CDC.GOV. Simplified Acquisition Procedures will be utilized.
- Place of Performance
- Address: 1600 Clifton Road, Building 17, Atlanta, GA
- Zip Code: 30329-0418
- Country: UNITED STATES
- Zip Code: 30329-0418
- Record
- SN01306220-W 20070602/070531220443 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |